HydRegen

📍 Oxford, United Kingdom🗓 Founded 2020👥 19 employees💰 Last funded Jan 2025
Biotechnology🌐 hydregenoxford.com
Website LinkedIn
HydRegen’s industrial biotechnology platforms deliver sustainable, safe and cost-efficient chemical processes. Partnerships with major chemicals companies have validated these technologies as ‘slot in’ replacements to precious metal catalysts, in existing chemical manufacturing infrastructure, providing a route to fast-tracking adoption of more sustainable bio-based manufacturing across the chemical sectors (current joint development projects in specialty, personal care, materials, and generics). By combining the benefits of milder biological conditions within intensified chemical infrastructure, we unlock at least 3xCO2e and 40% cost savings to our customers. We are now looking to raise £5-8m, focusing on delivering our first product (Bio2Amine) to a first 38 processes, with an end-market of £80bn and opportunity to HydRegen of £105m reoccurring revenue, before ramping our follow on products into additional markets. For Investors: https://hydregenoxford.com/investors
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in HydRegen?
HydRegen has 1 investors on record on gritt.io, 1 mid-stage.
When did HydRegen last raise funding?
The most recent investment in HydRegen recorded on gritt.io was in January 2025.
When was HydRegen founded?
HydRegen was founded in 2020.
What industry is HydRegen in?
HydRegen operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is HydRegen based?
HydRegen is headquartered in Oxford, United Kingdom.